Skip to main content
. Author manuscript; available in PMC: 2015 Jun 23.
Published in final edited form as: Chem Commun (Camb). 2013 Oct 28;49(84):9704–9721. doi: 10.1039/c3cc44268c

Fig. 2.

Fig. 2

Schematic representation of Egad MRI contrast agent; galactopyranose groups (red) are removed via β-galactosidase cleavage, resulting in an irreversible transition from a weak to a strong relaxivity state, reproduced with permission from ref. 28. Copyright 1997 Wiley-VCH Verlag GmbH & Co. KGaA.